China Money Network
Login
Join

China Industrial Asset Management Leads $40M Series C1 Round In Chinese Cancer Immunotherapy Company

  • November 26, 2018 — 11:16 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese cancer immunotherapy company Shanghai Cell Therapy Group Co. has raised RMB275 million (US$39.60 million) in series C1 round of financing from private equity firm... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: